Related Experiment Video
Updated: Apr 28, 2026
05:58
Clinical Microfluidic Chip Platform for the Isolation of Versatile Circulating Tumor Cells
Published on: October 13, 2023
2.0K
Nanostructured substrates for isolation of circulating tumor cells
Lixue Wang1, Waseem Asghar2, Utkan Demirci3
1Department of Oncology, The Second Affiliated Hospital of Southeast University, Southeast University, Nanjing, Jiangsu 210003, PR China.
Nano Today
|June 20, 2014
Summary
Circulating tumor cells (CTCs) are crucial for cancer metastasis research but difficult to isolate. Nanostructured substrates show promise for improving CTC isolation sensitivity and specificity in blood samples.
Area of Science:
- Biomedical Engineering
- Oncology
- Nanotechnology
Background:
- Circulating tumor cells (CTCs) are vital for understanding cancer metastasis and informing diagnosis, prognosis, and therapy.
- CTCs are rare in circulation, making their isolation challenging.
- Current CTC isolation methods face limitations in efficiency, specificity, and maintaining cell viability due to factors like shear stress and biomarker heterogeneity.
Purpose of the Study:
- To review the major challenges associated with current circulating tumor cell (CTC) isolation techniques.
- To explore the potential of nanostructured substrates as a promising platform for enhanced CTC isolation.
Main Methods:
- Literature review of existing CTC isolation techniques.
- Analysis of the advantages and limitations of nanostructured substrates for CTC capture.
- Discussion of challenges including sensitivity, specificity, and cell viability.
Main Results:
- Nanostructured substrates offer increased surface area and unique physical properties that can improve CTC isolation sensitivity.
- Challenges remain in achieving high specificity and preserving CTC viability due to inherent heterogeneity and isolation stresses.
- Further development is needed to optimize nanostructured platforms for clinical applications.
Conclusions:
- Improving CTC isolation efficiency and specificity is critical for advancing cancer research and clinical applications.
- Nanostructured substrates represent a promising avenue for developing next-generation CTC isolation technologies.
- Addressing challenges in sensitivity, specificity, and viability will be key to realizing the full potential of nanotech-based CTC isolation.
